The sales are small relative to market cap (0.023%) and follow a strong earnings beat, reducing the bearish signal. However, both the CEO and EVP sold without a 10b5-1 plan, which warrants monitoring for additional insider selling in the coming weeks. The next quarterly filing will show if this was a one-time portfolio adjustment or the start of a broader pattern.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $533.77entry
- T+1 · 11d ago −1.07%α −1.38% · $528.05
- T+5 · 5d ago +3.08%α −0.21% · $550.20
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Kevin McNamara and EVP Spencer Lee sold a combined $1.57M in open-market sales over two days, with no 10b5-1 plan. The sales follow Chemed's strong Q3 2026 earnings beat reported 9 days prior, where revenue grew 10.6% YoY and adjusted EPS rose 28.1% YoY, both above consensus.
Key Financial Metrics
Key Facts
- CEO Kevin McNamara sold 2,000 shares at $537.90 for $1.08M on 2026-11-03, no 10b5-1 plan
- EVP Spencer Lee sold 920 shares at $537.17 for $494K on 2026-11-02, no 10b5-1 plan
- Total open-market sales of $1.57M represent approximately 0.023% of Chemed's $6.9B market cap
- Sales occurred 7-8 days after Chemed reported Q3 2026 revenue of $690.9M (+10.6% YoY) and adjusted EPS of $6.75 (+28.1% YoY), both above consensus
Financial Impact
Total insider sales of $1.57M, representing 0.023% of market cap
Risk Factors
- Insider sales without a 10b5-1 plan could indicate management's view that the stock is fairly valued or overvalued after the recent earnings-driven rally
- Sales are small relative to market cap, limiting the bearish signal's materiality
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CHE-1793910900210 |
Track record
19 reports on CHE
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 6, 202610d ago Press Release Neutral 2/10 Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
- Nov 5, 202611d ago Insider Cluster Bearish 4/10 Viewing Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 27, 202620d ago 8-K Bullish 6/10 No price data
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
- Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
- Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers